Prevalence of the Pro12Ala missense mutation in the PPARG2 gene in Kuwaiti patients with primary knee osteoarthritis

ABSTRACT

Peroxisome proliferator-activated receptors [PPARs] play an important role in a number of cellular and metabolic functions. This study was carried out to determine the prevalence of a missense mutation [Pro12Ala] in the PPARG2 gene in Kuwaiti Arab patients with primary knee osteoarthritis [OA] and healthy controls with the aim of identifying a possible association. A prospective cross-sectional study carried out at three major teaching hospitals [referral centers] in the country over a one-year period. The prevalence of PPARG2 gene Pro12Ala missense mutation was determined in 104 Kuwaiti Arab patients with primary knee OA and 111 ethnically matched healthy controls. The prevalence of this Pro12Ala missense mutation was also determined in clinical subgroups of OA patients divided on the basis of age at onset, function and radiologic grading. The Pro-Pro genotype of the PPARG2 gene Pro12Ala missense mutation was detected in 95/104 [91.3%] cases compared to 111/111 [100%] in the control subjects. The heterozygous Pro-Ala genotype was detected in 9/104 [8.7%] of the OA patients, while it was not detected in any of the controls. The Ala-Ala genotype was not detected in any of the OA patients or the controls. No significant differences were detected in the PPARG2 gene Pro12Ala genotypes in the subgroups of patients classified on the basis of age at onset, functional assessment using Lequesne's functional index, and radiological grading using Kellgren-Lawrence [K-L] grading. This study found no significant association between the PPARG2 gene Pro12Ala missense mutation and knee OA. However, the presence of the Pro-Pro genotype of the PPARG2 gene mutation has a protective effect against development of OA